INTEGRA LIFESCIENCES HOLDINGS CORP - 8-K Filing
Integra LifeSciences reports Q3 2026 financial results with organic revenue growth and adjusted earnings guidance (Items: 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITIONOn October 21, 2026, Integra LifeSciences Holdings Corporation (the “Company”) issued a press re, 9.01 FINANCIAL STATEMENTS AND EXHIBITS(d) Exhibits99)
Tickers: $IART
Read the full article at SEC EDGAR
Part of the story ALASKA AIR GROUP, INC. - 8-K Filing (3 articles)